AlzeCure Pharma’s Rights Offering

Maha Kanaan Europe Legal Chronicle
Tagged:

Synch acted as legal advisor to AlzeCure Pharma.The board of directors for AlzeCure Pharma has resolved a rights issue of approximately SEK 53 million. In addition,the…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Maha Kanaan

Author: Maha Kanaan

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here